Trial Profile
Efficacy of sofosbuvir and ribavirin in patients with genotype 2 HCV infection with cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2016
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Dec 2016 New trial record
- 10 Dec 2016 Results published in the Journal of Hepatology